InsidersTradesSigma
Track the 씨엑스아이 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 씨엑스아이 has published 55 reports. Market capitalisation: €38.8bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: LIN JINSHENG. All data is accessible without an account.
48
Insider Decl.
n/a
Thresholds
n/a
23 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Fundamental score
Ranked 399 of 29,063 companies
85.8
score / 100
Value100
Quality72
FCF yld·
Earn yld76%
EV/EBITDA0.7x
ROE1.6%
Gross mgn43%
Net mgn42%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations55 total
Other
Other
Other
Other
Other
Other
Other
1,700,000 sharesShareKRXDART:20260716000366
1,700,000 sharesKRXDART:20260716000363
2,513,972 sharesKRXDART:20260316000488
25,000,000 sharesKRXDART:20260312001274
6,776,547 sharesKRXDART:20260312001139
37,060,509 sharesKRXDART:20250825000363
ShareKRXDART:20241125000281
15,000,000 sharesKRXDART:20241125000268
ShareKRXDART:20241125000272
0KRXDART:20241125000273
25,000,000 sharesKRXDART:20241031000416
ShareKRXDART:20241018000499
25 of 55 declarations
关于 씨엑스아이
씨엑스아이是一家在XKRX市场上市的医疗保健和制药公司。它专注于药品的开发和商业化。